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Introduction 
Tumor induced angiogenesis is the formation of new blood vessels around the tumor 
microenvironment for supporting expansion of the tumor mass (Hanahan and Folkman, 
1996). Tumor  vessels  can arise by angiogenic sprouting (Folkman et al., 1971), 
intussusception (Folkman et al., 1971), or by recruiting endothelial precursor cells from the 
bone marrow (Lyden et al., 2001). In addition, tumor cells may also co-opt existing blood 
vessels from the host (Holash, Maisonpierre et al., 1999). 
Tumor growth strictly depends on adequate supply of oxygen (O2) through blood vessels. 
Vascularization determines pathophysiological characteristics of the tumors, such as tumor 
invasiveness and metastasis formation. Moreover successful therapy critically depends on 
the transvascular delivery and permeability of larger molecules into the  tumor tissue. 
Therefore quantification various aspects of the tumor vasculature provides valuable tools for 
tumor prognosis. 
However the degree of vascularization is not a homogeneous measure, it depends on the net 
balance between proangiogenic and antiangiogenic factors stimulating and inhibiting vessel 
growth respectively, as well as on nonangiogenic factors, such as O2 and nutrient 
consumption rates of tumor cells. Recently also the effect of  the host microenvironment in 
the tumor circulation was fully realized (Fukumura et al., 1997). The molecular components 
involved in tumor induced vascularization include hypoxia-inducible transcription factors, 
which trigger a coordinated response of angiogenesis by inducing expression of  growth 
factors (GF) (Maxwell et al., 1997; Plate and Risau, 1997).  Individual tumors can produce a 
variety of proangiogenic GFs, among which members of vascular endothelial growth factor 
(VEGF) and angiopoietin family have a predominant role, all inducing endothelial cell 
differentiation, proliferation and increase in vessel length [reviewed in: (Carmeliet and Jain, 
2000)]. VEGF also exerts morphogenic activity by increasing luminal diameter of existing 
vessels (Zhou et al., 1998). Angiogenic inhibitors, suppressing proliferation and migration of 
endothelial cells include thrombospondin-1 (Jiminez et al. 2000), angiostatin (O’Reilly et al., 
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1994) and endostatin (O’Reilly et al., 1997). They are produced either by the tumor or by the 
host stromal cells, cause endothelial cell apoptosis and may be involved in tumor dormancy.  
Increased cellular proliferation in tumors also results in a switch from O2 consuming to 
glycolytic pathways providing tumor cells with an alternative energy source during low O2 
supply (Iyer et al., 1998; Minchenko et al., 2002). However, each tumor has a minimum O2 
consumption rate, characteristic for its metabolic demand, below which tumor cells loose 
viability, the rate varying with tissue origin and with tumor progression. Thus the minimum O2 
and nutrient consumption will limit how far away from the vasculature tumor cells can remain 
viable, the number of viable tumor cell and their GF production in turn will regulate  vascular 
density,  blood flow, and permeability. 
Tumor vessels are abnormal in many ways, they show uncontrolled permeability, are 
tortuous and dilated, have excessive branching, shunts and undergo constant regression and 
remodelling. This may be due to an imbalance of angiogenic regulators such as VEGF and 
angiopoietins, giving rise to chaotic blood flow, unstable, leaky vessels (Maisonpierre et al., 
1997). The tumor endothelium has widened inter-endothelial junctions, discontinuous or 
absent basement membrane with loosely associated mural cells (Hashizume et al., 2000). In 
addition to regulatory mechanisms achieved by angiogenic factors and structural properties 
of the  vessel wall, haemodynamic conditions, especially flow and shear stress (Cullen et al., 
2002; Milkiewicz et al., 2001), play a decisive role in maintaining high vascular permeability, 
inhomogeneous diameter, and concomitant collapse typically observed with tumor blood 
vessels. It is generally acknowledged, that increase in blood flow contribute to vessel 
enlargement in any vessel, whereas disturbed flow or severe reduction of blood flow is 
associated with apoptosis of endothelial cells and vessel regression (Dimmeler and Zeiher, 
2000).  
Although recent insights in the molecular basis of angiogenesis have resulted in the 
discovery of many new angiogenic molecules, many questions remain unsolved. So far very 
little is known about the spatial cues guiding endothelial cells into correct patterns and three-
dimensional networks. One of the basic questions is: whether the quantification of some 
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aspects of the vascular network formation can make predictions for tumor progression in 
patients and if yes, what are these aspects. 
From what we have described so far it appears that a theoretical model describing 
quantitatively the dynamics of the remodeling process of the vascular network during tumor 
growth should contain at least the following aspects: 1) A pre-existing network representing 
the normal vasculature that can be modified dynamically via growth, regression and 
modification of its links (representing blood vessels), 2) A nucleus of tumor cells that can 
proliferate, age and die, 3) At least two concentration fields: one whose sources are the 
vessels of the network and represents oxygen and other nutrients, and one whose sources 
are the tumor cells and which represent GFs, 4) A model for the hemodynamic flow within 
the network, 5) A set of dynamical rules that describe a) the process of interaction between 
vessels and tumor cells mediated by the two concentration fields and b) the influence of the 
blood flow. One intention of our paper is to show that a number of phenomena, like the 
systematic compartmentalization of the tumor into rapidly vascularizing periphery and 
necrotic regions and other morphological details of tumor vasculature are already a 
consequence of the aforementioned five inputs. 
Previous attempts to describe mathematically the growth of tumor vasculature either focused 
on a particular model for  angiogenesis in presence of a GF source alone (Anderson and 
Chaplain, 1998; Levine et al., 2001) or studied tumor growth within a vascular network of 
fixed topology but with hydrodynamically generated inhomogeneities (Alarcón et al., 2003). 
From a physicists point of view the tumor/vessel system appears as a dynamically evolving 
weighted network or graph with a hydrodynamic flow imprinted on it, plus a non-trivial growth 
process (including birth and death) in continuous or discrete time and space, both interacting 
non-locally via several diffusion fields. This is a rather complex physical system which has 
not even been tried to analyze up to now and it turns out to be possible only numerically  
using methods inspired by computational physics. Therefore we define the model in the next 
section in terms of the elementary stochastic processes, which in principle could also be 
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formulated in terms of a Master equation (van Kampen, 1992), implement them in a Monte-
Carlo simulation and present and discuss the result in the subsequent sections. 
 
 
Definition of the model 
A clinical case of a human melanoma type tumor was chosen (Döme et al., 2002) as the 
experimental basis of the theoretical model and other selected experimental data available 
from solid tumors are also involved. In the model we assume, that tumor induced 
neovascularization starts with two parallel processes, cooption of existing vessels and vessel 
sprouting. We do not consider recruiting endothelial cells from the bone marrow. 
A hybrid probabilistic cellular automaton model is defined on a square lattice with N=L2 sites 
with coordinates r=(nx∆r, ny∆r), nx,ny ∈{1,…,L} and in discrete time τ=n∆τ, with n=0,1,2,... 
Each site represents an area ∆r2 with ∆r=10µm, which is approximately the size of a single 
EC or TC, and each time step represents a time interval of length ∆τ=1hour. Table 1 lists the 
dynamical variables that define the state of each site at time τ. For instance e(r,τ)=1 (or 0) 
means that a vessels segment is present (or absent) at site r and time τ, its radius (if 
present) is given by er(r,τ), its blood flow rate by eQ(r,τ) and its wall shear stress value ef(r,τ). 
If t(r,τ)=1 (or 0) TCs are present (or absent) at site r and time τ, tuO(r,τ) is the time it spent in 
an underoxygenated state. GF and O2 concentration at site r and time τ are given by cGF(r,τ) 
and coxy(r,τ), resepectively. In each time step these variables are modified probabilistically 
according to the rules listed below, which depend on various fixed parameters listed in table 
2. 
The initial state of the system at τ=0 represents a regularly vascularized region of a given 
micro-vascular density MVD0 with a small tumor in the center, c.f. Fig. 1a: Vessels are 
arranged in a regular pattern, which for simplicity is chosen to be a “Manhattan network” with 
a lattice constant a (e.g. a=100µm yields MVD0=100 vessels per mm2 in 3 dimensions). This 
means that e(r,τ=0) =1 and er(r,τ=0)=r0 for r=(n⋅a,y) and r=(x,n⋅a) with n=0,1,2,…,L/a and 
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x,y=0,1,2,…,L. All other sites have e(r,τ=0)=0. For the initial tumor it is t(r,τ=0)=1 in a region 
containing TC0 sites determined probabilistically  according to the Eden growth rule (Eden, 
1961).  
In the next time step, and in all subsequent time steps, the following computations are 
performed one after the other in a Monte Carlo simulation, yielding the new system state at 
time τ+∆τ, which is evaluated for several quantities of interest. The simulation is stopped 
either if the tumor reaches the system boundary or if it ceases to exist (depending on the 
chosen parameter values). We did not incorporate any mechanism resulting in the inhibition 
or arrest of tumor growth here. 
 
Definition of the GF concentration field cGF(r,τ): Each TC synthesizes a certain amount of GF 
and the sum of GF secreted creates a GF concentration field around the tumor. GF (e.g. 
VEGF) expression is known to be regulated under hypoxic conditions in TC-s (Plate et al., 
1992; Shweiki et al., 1992) suggesting that GF concentration might depend on synthesis rate 
around various TC sites, but the existence of a  matrix storage pools for GF (Goerges and 
Nugent, 2004) would rather predict a generation of a preformed GF gradient in the very close 
vicinity of TC-s. Therefore in our model we defined GF concentration such a way, that it is a 
final result of all TC processes and assume a linear decrease of the GF pool of each TC up 
to a radius RGF: 
cGF(r,τ) = Σ{r’ with e(r’,τ)=1} fGF(|r-r’|), 
where the sum is over all TCs at time τ, fGF(r)=(RGF-r)/N for r≤RGF and fGF(r)=0 for r>RGF and 
the normalization N chosen such that ΣrfGF(|r|)=1. 
Identification of circulated sites Scirc(τ):  For each vessel segment (i.e. each site r with 
e(r,τ)=1) it is checked whether it is located on an uninterrupted path in the current vessel 
network that connects the sites (0,0) and (L,L). Technically this check is performed by 
computing the bi-connected components (Tarjan, 1972) of the graph underlying the vessel 
network. If this condition is fulfilled, blood can flow through this vessel and r is a member of 
the set of circulated vessels Scirc(τ). 
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Definition of the oxygen concentration field coxy(r,τ): Intensive cellular proliferation in tumors 
results in an increase in oxygen demand, TC-s remain viable within a certain radius around a 
vessel, generating  “cuff”-s on the available oxygen concentration field (Hlatky et al., 2002). 
However the maximal radius of oxygen concentration field, that still supports TC proliferation 
(“cuff size”)  depends both on the oxygen concentration released from a vessel and on the 
consumption of oxygen by TC-s, modeled by an oxygen concentration threshold  θoxy defined 
below. For simplicity we do not calculate coxy(r,τ) via the stationary solution of a diffusion 
equation with vessels as sources and TCs as sinks, but assume that the O2 supply of 
individual vessel segments depends mainly on circulation.  
coxy(r,τ) = Σ{r’∈S-circ(τ)} foxy(|r-r’|), 
where foxy(r)=(Roxy-r)/N’ for r≤Roxy and foxy=0 for r>Roxy. The normalization constant N’ is 
chosen such that Σrfoxy(|r|)=1.  
TC proliferation: It is assumed that only TCs with at least one free neighbor site can 
proliferate. If the local O2 concentration coxy(r) at such a tumor surface site r exceeds a 
threshold θoxy this site is occupied with a TC with probability w(t(r,τ)=0→ t(r,τ)=1)= ∆τ/Tt and 
cGF(r,τ) is updated. Tt estimates the tumor proliferation time, which can vary enormously with 
different tumors (Hirst et al., 1982). 
EC proliferation, sprouting and sprout migration: Adult normal vessels are quiescent, 
whereas EC-s in pathologic tumor vessels are stimulated to proliferate and migrate by a local 
increase in GF concentration to form sprouts (Risau, 1997), migrate and either meet with an 
other EC forming a tube, or retract (Nehls, 1998). In vascularized tissues like melanoma 
(Paku, 1998) TC-s also use existing vessels and the high density of anastomosing network 
(interconnected vascular tubes) arises from an interplay between cooption of old vessels and 
subsequently induced sprouting (Thompson et al., 1987; Holash, Wiegand, and 
Yancopoulos, 1999). The latter scenario was applied in our model:  
New straight vessel segments between two circulated vessels at site r and r’ are introduced 
with probability ∆τ/Te (where Te is the EC proliferation time) if: cGF(r,τ)> θGF, no site in the 
migration path is occupied by TCs, no site and no neighbor site of the migration path is 
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occupied by ECs except r and r’, and |r-r’|<Mmax (Mmax being the maximum sprout migrgation 
distance). In case of such an event e(r,τ)=1 and er(r,τ)=r0 along this path, and Scirc(τ) and 
coxy(r,τ) are updated. 
Vessel dilation: Vessel diameter increases in response to GF, vasodilation is reported to 
occur concomitantly with capillary growth (Carmeliet and Jain, 2000). Vessel perimeters were 
found to be increased inside the tumor, in the tumor center EC-s were suggested to 
participate in vessel dilation (Döme et al., 2002).  
In our model a vessel segments at site r that is surrounded by TCs and has a GF 
concentration cGF(r,τ) larger than θGF increase its radius er(r,τ) by an amount r0/2π with 
probability ∆τ/Te as long as er≤rmax. To mimic the smoothening effect caused by the surface 
tension of the vessel walls the location of the dilation is shifted to a neighboring vessel 
segment if a radius difference larger than r0/2π would arise at the original location.  
Blood flow and shear stress computation: The shear stress exerted by the blood flow upon 
the vessel walls is considered to be a principal stimulus for EC-s, the primary driving force for 
vessel architecture (Davies, 1995; Ishida et al., 1997). For a given vessel network we identify 
the vessel segment with cylindrical tubes of radius er(r,τ) and approximate the flow through it 
by laminar steady Poiseulle flow of a homogeneous liquid. We neglect here the fact that 
blood is an inhomogeneous fluid which is commonly modeled by a radius dependent 
viscosity. Then the flow rate is determined by the pressure drop  ∆P between the end points 
of the segments:  
eQ(r,τ) = Q/∆τ = const⋅ er4(r,τ) ⋅∆P. 
The boundary conditions for the pressure are defined in such a way that a homogeneous 
flow distribution in the vessels of the original network arises: The pressure in the vessel 
segments decreases linearly on the boundary vessels from Pmax at r=(0,0) to (Pmax-Pmin)/2 at 
r=(L,0) and r=(0,L), and from there from (Pmax-Pmin)/2 to Pmin at r=(L,L), resulting in 
homogeneous global net flow in the diagonal direction. Since only pressure differences enter 
the flow equations Pmax and  Pmin can be chosen arbitrarily and are set to 1 and 0, 
respectively, in arbitrary units. Using Kirchhoff’s law we calculate the pressure drop and flow 
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in each vessel segment. The shear stress ef(r,τ) acting upon the vessel walls of each vessel 
is given by ef(r,τ)= const⋅ er(r,τ) ⋅∆P. 
Vessel collapse: Focal necrosis is commonly observed in solid tumors in regions, where the 
vascular network is inadequate (Griffon-Etienne et al., 1999; Ramanujan et al., 2000). 
Reduced perfusion of these vessels can be the result of a solid stress of neighboring tumor 
cells causing the collapse of vessels, or due to apoptosis of ECs induced by local inhibitors 
of angiogenesis (Dimmeler and Zeiher, 2000). Long-term reduction of wall shear stress is 
associated with dramatic reduction of the vessel diameter, up to complete vessel occlusion. 
We used both criteria to identify critical vessels: circulated vessels, which are surrounded by 
TCs, collapse with probability p=∆τ/Tcollapse if the wall shear stress ef(r,τ) is below a critical 
value fcrit, c.f. Fig. 1b-d. After each collapse event e(r,τ)→0 first the set of circulated sites 
Scirc(τ) and then coxy(r,τ) is updated. 
EC death:  Vessel network sites r that are not circulated and under-oxygenated 
(coxy(r,τ)<θoxy,EC) are eliminated with probability ½. θoxy,EC is set 10 times higher than the  
corresponding threshold for TCs, see below. 
TC death: TCs adapt their metabolism to hypoxic conditions, therefore  θoxy,TC is set 10 times 
lower as θoxy,EC. TC lifespan under hypoxia and normoxia is difficult to estimate because 
hypoxia was found to induce apoptosis of TCs but simultaneously lead to selection of p53 
deficient colonies induced in hypoxic regions (Yu et al., 2002).  
In our model a TC is eliminated with probability ½ only if O2 concentration is under the low 
(adapted ) θoxy,TC for a time TuO, c.f. Fig.1c-d. After elimination cGF(r,τ) is updated. 
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Results 
Base case scenario: 
A scenario is chosen to describe a melanoma type tumor, characterized by a small GF 
threshold (θGF=0.01), a large GF activation radius (RGF=200µm), a large O2 threshold 
(θoxy,TC=0.05), a small O2 diffusion radius (Roxy=100µm), relatively high vessel collapse 
probability (∆τ/Tcollapse=0.1 and fcrit=0.5f0). We set Te to 40∆τ and Tt to 10∆τ. Fig.1. 
demonstrates the time evolution of the tumor and vessel configuration in the model with the 
set of parameter values above (see also table 2). 
At late stages of the emergence a phenomenological compartmentalization becomes 
transparent, see Fig. 2: 1) The outer region close to the tumor surface (peritumoral tissue) is 
highly vascularized by thin vessels, its thickness depends on  θGF and RGF; 2) a well 
circulated tumor region (tumor periphery) containing vessels grown via sprouting in the outer 
shell and then enclosed by the growing tumor; 3) the intermediate region inside the tumor 
with lower MVD and thicker vessels; 4) the necrotic core with only a few large and stable 
vessels enclosed by a cuff of TCs, the thickness of which depends on θoxy and Roxy. The 
border between regions 2 and 3 is diffuse.  
A quantitative analysis of this time evolution is performed as follows: At each time MVD, O2 
and GF concentration, vessel radius, shear stress, blood flow and pressure inside the 
vessels  are calculated as a function of the radial distance r from the tumor center. Results 
for the tumor density and MVD is shown in Fig. 3. The peak in the height profile of the tumor 
density indicates the boundary of the tumor (stochastic fluctuations in the TC proliferation as 
well as inhomogeneities in the O2 concentration cause the finite width of this step). The tumor 
radius Rtumor(τ) = max { r | D(r,τ)=1/2 }, also shown in Fig. 3a, grows linearly with time, a fit 
yields Rtumor(τ) = 0.21⋅τ + 60 (time and radius measured in units of ∆τ and ∆r, respectively). 
The radial growth rate (0.21) is approximately twice the TC proliferation rate (∆τ/Tt=0.1), 
which is typical for Eden growth. As long as the peritumoral vessel plexus develops fast 
enough (small θoxy,EC, large RGF) Rtumor(τ) displays the same time dependence. 
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At the peak DT develops a plateau of width ~ 50∆r before it decreases substantially due to 
the appearance of necrotic regions in the tumor center. The irregularities in the density profile 
reflect the exact spatial locations of these necrotic regions, which is random. An average 
over several realizations of the stochastic process that is described by our model would 
remove these fluctuations and yield smooth curves. This remark holds for all Figs 3 and 4. 
The average growth factor concentration cGF(r,τ) has approximately the same shape as the 
tumor density, which is due to the fact that all viable TCs contribute to  cGF(r,τ) in the same 
way (data not shown). 
Fig. 3b shows the MVD, which has a sharp maximum at a radius RMVD(τ), corresponding to a 
highly vascularized tumor periphery,  which evolves also linearly with time. A fit yields RMVD(τ) 
= 0.21⋅τ + 60, implying that it is identical with the tumor radius Rtumor(τ) and demonstrating the 
appearance of a  highly vascularized region in the peritumoral tissue. For radii r<RMVD(τ) the 
MVD drops quickly (within ca. 50∆r) to values around the normal tissue MVD0 before slowly 
decreasing to values significantly lower than MVD0 (corresponding to a poorly vascularized 
tumor center). The O2 concentration profile coxy(r,τ) (not shown) has approximately the same 
shape as MVD(r,τ) reflecting the fact that all vessel segments contribute in the same way to 
coxy(r,τ). Hypoxic conditions in the tumor center can thus immediately be read off from the 
MVD. 
The average vessel radius is found to grow linearly with time inside the tumor, as can be 
seen in Fig. 4a. The maximum vessel radius, set to rmax=3.5∆r, appears as a plateau at 
sufficiently large times. This behavior is characteristic for a situation in which the GF 
concentration cGF(r,τ) inside the tumor (r<Rtumor(τ)) is always larger than the actual GF-
threshold (θGF).  
The average blood flow per vessel, shown in Fig.4b, increases proportional to (Rtumor(t)-r)4 
towards the tumor center, due to the fact that the flow depends on the 4th power of the vessel 
radius, which increases linearly according to Fig. 4a. Finer variations of the flow in the 
peritumoral region are present but not visible on the chosen scale, but see Fig. 4c.  
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The shear stress F(r,t) acting upon the vessel walls is shown in Fig. 4c. It displays a 
pronounced dip where the MVD (Fig. 3b) has its maximum, i.e. in the peritumoral plexus. 
This is due to the fact that an increased MVD in some region reduces the average blood flow 
per vessel and concomitantly the shear stress F. According to the definition of the model 
vessels with F<Fcrit (=0.5F0 here) can collapse resulting in MVD decrease, flow increase and 
shear stress increase – which is visible in Fig.4c towards the tumor center.  
Fig. 4d shows the difference between the blood pressure in the vessel at location (x,y) in the 
normal vasculature and the blood pressure in the tumor vasculature at time t=600, 
normalized to the maximum pressure in the upper left corner (x=0,y=0). The blood pressure 
gradient in the tumor center is up to 50% lower than in  normal vessels in spite of the 
decreased MVD. This is due to dilated vessels with a blood flow capacity up to 200 times 
larger than that of normal vessels (Fig. 4b).   
We determined the fractal dimension df of the vascular network with the box-counting method 
(Mandelbrot, 1982) with boxes ranging from lateral size 1∆r to 100∆r, the result is shown in 
Fig. 5, and find it to depend on the tumor region to which the analysis was restricted.  The 
original vasculature has df=2.0 per construction since the Manhattan pattern represents a 
compact structure. The complete vasculature that was altered by the tumor has 
df=1.85±0.05, concurring with the estimate for the capillary network of various carcinoma 
(Gazit et al., 1995). The restriction of the analysis to concentric annular rings of width 50∆r 
yields a value of df=1.60±0.05 for the peritumoral region and slightly decreasing values for 
decreasing radii of the rings reflecting the increasing sparseness of the vessels towards the 
tumor center. All measurements of fractal aspects of tumor vasculature suffer from the fact 
that the possible box-sizes span only 2 decades (in real tumors as well as in our model): The 
minimum size is ca. 10 µm (approximately the minimum diameter of a capillary) and the 
maximum is around 1mm (for a tumor of size 5-10mm). Taking into account error bars and 
transient regimes it is clear that a precise estimate of df is hardly feasible. Differences in df of 
the order of 0.1 are, however, significant, and indicate that the local values for df correlate 
strongly with local values for the MVD. 
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Parameter dependencies: 
 
In the following we analyze the various paramter dependencies of the model. Since tumor 
growth in our model depends strictly on the concentration field coxy(r) it is usefuld to clarify the 
shape of this field in the original vasculature, which is shown in Fig. 6 for different values of 
the lattice constant of the original vasculature a (i.e. different values of the original MVD0 = 
1/a2). The oxygen concentration in the original tissue varies spatially only within a few percent 
when Roxy≥a and its mean value c0oxy is proportional to MVD0. TCs at the tumor surface will 
always survive and proliferate when θoxy< c0oxy. On the other hand when θoxy>c0oxy or when  
Roxy is smaller than a the regions between two neighboring vessels in the original network 
have a O2 content much lower than c0oxy (or even zero if Roxy <a/2), the survival and eventual 
growth of the tumor becomes probabilistic and depends upon the speed with which new 
vessels are formed – survival probability decreases drastically in this parameter region and 
the tumor morphology can become non-circular and even disconnected. In later stages of the 
tumor growth Roxy and θoxy determine the diameter of the cuffs surrounding the large vessels 
inside the necrotic regions of the tumor. 
To clarify the effect of RGF and θGF we show the GF concentration field cGF(r) produced by an 
ideal circular tumor density 1 and radius 50∆r in Fig. 7a. In the tumor center cGF(r)=1 due to 
the normalization of the function fGF(r). At the boundary the concentration profile decreases in 
a sigmoidal shape from 1 to 0 over a width of 2RGF, being 0.5 approximately at the tumor 
surface. In Fig. 7b we show cGF as a function of the distance r from the tumor surface for 
different values of RGF. cGF scales linearly with RGF which implies that the limit of EC growth, 
i.e. the width of the region outside the tumor with increased MVD, increases linearly with RGF, 
as is illustrated by the straight line at cGF=0.05, from which the maximum width of this region 
can be read off for the case θGF.  
A non-trivial consequence of large values of RGF (e.g. 40∆r), which produce a wide and 
dense vasculature in the peritumoral region, is that they are accompanied by larger MVDs 
also inside the tumor thus inhibiting the emergence of necrotic regions for a large range of 
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collapse probabilities and critical flows - Fig. 8a shows an example of a Monte-Carlo 
simulation for RGF=40∆r and all other parameters as in the base case.  
The collapse probability pcollapse=∆τ/Tcollapse and the critical shear stress fcrit determine the total 
necrotic volume and the total vessel number, as is demonstrated by the examples shown in 
Fig. 8b and Fig. 9. In Fig. 8b all parameters are the same as in Fig. 8a, only fcrit is changed 
from 0.5 to 0.7 , which means that higher flow values are necessary to stabilize vessel. This 
moderate change decreases MVD inside the tumor drastically and produces large necrotic 
regions. In Fig. 9 a series of configurations with increasing collapse probability pcollapse is 
shown. The necrotic volume relative to the total tumor mass as well as total number of 
vessels is shown in Fig. 10 as a function of time for different collapse probabilities (fcrit=0.5 
and the other parameters as in the base case), the necrotic volume relative to the tumor 
mass starts to increase with time for t>tuO and saturates around t=500, ranging from 0.2 for 
pcollapse=0.05 to 0.35 for pcollapse=0.5. This means that the tumor has reached a more or less 
stationary state in which a constant fraction of the tumor mass is necrotic, except for very 
small values of pcollapse, where the necrotic regions are confined to a small region at the tumor 
center:The data for pcollapse=0.015 show a slow decrease in the relative necrotic regions for 
t>500. The total number of vessels at time t decreases linearly with time for pcollapse>0.05, and 
decreases with increasing pcollapse. E.g. for pcollapse=0.5 (and again the other parameters as in 
the base cae) the total vessel number in the system is 25% less than the total vessel number 
in the original tissue (in the space region considered) after t=1000 time steps although the 
MVD is substantially increased in the peritumoral region. Only for small values of pcollapse the 
MVD increases for t>500, concomitantly with the decrease in relative necrotic volume: Since 
vessel collapse is rare the increased MVD in the peritumoral region also survives iinside the 
tumor.  
The TC proliferation time Tt determines the tumor growth speed in well oxidized regions. The 
EC proliferation time Te determines the speed with which new vessels are formed in regions 
with sufficient GF and therefore also effects the tumor growth speed if θoxy is smaller than the 
critical value (0.12 for MVD0=100/mm2). 
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Discussion 
Within the base case scenario we have demonstrated that the model reproduces the spatially 
resolved experimental data of (Döme et al., 2002) for vessel radii and MVD in melanoma. 
The model can also be adopted to other tumor growth scenarios, ranging from tumors with a 
low oxygen demand that exclusively coopt pre-existing vessels to tumors that produce a 
characteristic peritumoral vascular plexus because of high oxygen demand or high GF 
production rate. It also describes scenarios in which tumors are completely filled with viable 
TCs and high MVD in the center on one side and morphologies containing large necrotic 
regions and only a few very thick vessels on the other side.  
An important prediction of our model is that large parts of the vascular network can be cut off 
from the blood circulation by only a few vessel collapses. Consequently the emergence of 
necrotic regions does not necessarily rely on the presence of large amounts of anti-
angiogenic factors (Ramanujan et al., 2000). We find that failure of only a few vital ECs 
induced by the local mechanical pressure of high tumor densities might also be sufficient to 
disrupt the oxygen supply of a whole region leading to massive cell death therein. The vessel 
segments need not only to be connected to the exterior network via an uninterrupted path but 
at least bi-connected (equivalent to the existence of at least two link-disjoint, uninterrupted 
paths) in order to be circulated by the blood flow, which lowers the number of collapses that 
would lead to the necrosis of a region even further. 
Vessel collapse events have been shown to correlate with elevated levels of solid pressure 
exerted by the growing tumor on the intratumoral vessel wall (Boucher and Jain, 1992), 
which is considered qualitatively in the present version of our model by the criterion that 
collapse events only occur, if the vessel is surrounded by TCs. Varying stiffness of the 
surrounded matrix in different tumors can phenomenological be described in our model by 
varying values for the collapse probability.  
In addition to the criterion that vessels are surrounded by TC-s, shear stress was chosen as 
a second parameter to correlate collapse events. This was motivated by the data obtained on 
normal vessels, where temporal changes in the haemodynamic flow pattern causing locally a 
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decrease in wall shear stress were shown to lead to a structural reduction of the internal 
vessel diameter (Pries et al., 1995). We suggest therefore that for a vessel which is 
surrounded by TC-s (also exerting solid stress) such a contraction could lead to complete 
collapse.   
Another important prediction is that vessel collapse and the local blood flow characteristics 
have to be correlated via the local shear stress. If the collapse events would occur 
independent from one another with some probability p, a fundamental law in percolation 
theory (Stauffer, 1992) predicts that either the interior of the tumor is completely filled (i.e 
does not contain large connected necrotic regions) or it is completely void up to a small 
boundary region – except for one special value for the parameter p, the percolation threshold 
pc. We confirmed this scenario by testing different model variants containing uncorrelated 
collapse events (see Appendix). The existence of a model parameter like the collapse 
probability that has to be fine-tuned to a special value in order to reproduce vessels that 
thread the whole tumor would obviously be unsatisfactory. Only if we correlated the vessel 
collapse with the shear stress the model predicts a realistic vascular network morphology 
that is robust against parameter variations. The basic mechanism for this robustness is the 
redirection of the flow after collapse events into still intact vessels resulting in an increased 
shear stress in the remaining vessels and thus a drastically reduced collapse probability. 
Shear stress rather than blood flow as a hemodynamic criterion for vessel stability appears to 
be plausible, since the ECs in the vessel wall only have (mechanical) information about the 
shear stress (via the glycocalix) but not on the total flow. We checked that a correlation of 
vessel collapses with the blood flow also leads to unrealistic network morphologies in which 
only a few vessels survive within the whole tumor (i.e. a tumor periphery with increased MVD 
is completely missing). The reason for this is the dependence of the flow from the fourth 
power of the vessel radius. This leads to a strong variation of the flow between vessels of 
only slightly different  radius implying the survival of only the thickest vessels if collapse is 
correlated with the flow. 
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Blood vessels are exposed not only to shear stress but also to the transmural pressure. 
Since the physiologically relevant difference between the microvasular pressure and 
interstitial fluid pressure is generally very low in tumor vessels due to their leakiness 
(Boucher et al., 1996), the pressure-shear hypothesis (Pries et al. 1995) implies an 
adaptation of the vessel walls towards low equilibrium shear-stress via vasodilation. Together 
with the effect of GF this mechanism explains the ubiquitous presence of dilated vessels in 
tumors. Nevertheless blood pressure in tumor vessels remains enigmatic: It is usually larger 
than the pressure in normal vasculature in spite of the increased MVD and larger vessel 
diameter in tumors. In addition to geometrical effects also the solid stress exerted by the 
tumor might play an important role. It appears promising to incorporate solid stress into our 
model, by using a continuum description for the growing tumor. 
The analysis of the parameter dependencies of our model revealed that the morphology of 
the tumor vasculature depends most strongly on  the potential width of the peritumoral plexus 
(related to the diffusion range of the growth factor molecules) and on  the way in which the 
process of vessel collapse takes place. Varying the probability with which vessels can 
collapse translates immediately into a variation of the necrotic volume, even more 
dramatically upon variation of the critical shear force. 
A general feature of the remodeling process of the normal vasculature into the tumor 
vasculature in our model - and we propose this to hold also for in vivo tumors - is that none of 
the initial characteristics of the original vessel network survives this process: We assumed a 
original vascular network that consists of capillaries of equal diameter arranged in a regular 
grid with a given MVD, which guarantees a homogeneous distribution of oxygen and a 
constant shear stress in all vessels. Once the tumor grows over it, it gets transformed into a 
compartmentalized network with irregularly arranged dilated vessels and a decreasing MVD 
from the tumor periphery to the tumor center, resulting in an inhomogeneous oxygen 
distribution.
Variations in the structural characteristics of the original vascular network will not influence 
the compartmentalization of the tumor reported here but will certainly have implications for 
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the emerging network morphology and for the absolute values of microvascular pressure. For 
instance we observe a global directedness of the central vessels in our model, which is a 
consequence of the boundary conditions for the hydrodynamic pressure that we assumed, 
which imprints a global net flow in one particular direction through the tumor. The resulting 
pressure distribution within the whole network has a diagonal gradient, with higher pressures 
always on the upper left side of the tumor and lower pressure on the lower right side. Natural 
vascular networks are organized in arterial and venous trees connected by capillary beds, 
with blood pressure generally decreasing from arteries over arterioles to capillaries and 
venoules. Their pressure distribution has therefore a structural basis. It would be useful to 
initialize our model with an original network that is organized in the same way, because then 
one can also expect to obtain a realistic distribution of the absolute values of the 
hydrodynamic pressure within tumor vessels. The modulus of the pressure gradient within 
tumor vessels should, however, remain decreased towards the tumor center, as in the 
present version of our model. 
The fractal analysis of the tumor vasculature predicted by our model showed that for the 
base case scenario the fractal dimension df is around 1.85, which is close to the value found 
in various carcinoma (Gazit et al., 1995). There it has been emphasized that this value 
corresponds closely to the one for invasion percolation, which is 1.89 (Stauffer and Aharony, 
1992) relating the growth of tumor vasculature to the expansion of a network throughout a 
medium with randomly distributed heterogeneities in strength. Our model does not involve 
any heterogeneity aspects of an extracellular matrix surrounding a growing tumor, 
nevertheless the fractal characteristics of the tumor vasculature turns out to be similar to the 
one of real tumors.  
The tumor radius grows always linear with time in the model and depends strictly on the TC 
proliferation time. Only in the case of low original MVD it depends on the speed with which 
the peritumoral region expands into the underoxygenated areas via sprouting. The tumor 
would stop growing if the MVD in some region of the original tissue is substantially smaller 
than necessary for TC proliferation, depending on θoxy and Roxy. In the examples we 
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discussed here it grew linearly because we assumed a homogeneous original tissue. Other 
possible growth limiting factors include growth inhibitors either produced by the TCs or the 
host tissue, which could be added as new concentration field into our model, and solid stress 
generated by a growing tumor in a confined space (Helmlinger et al., 1997) also elevating 
microvascular pressure (Griffon-Etienne et al., 1999). However involvement of solid stress 
into the model would lead to a mechanism for growth inhibition only in later stages of tumor 
development, at present the maximum diameter of the tumor we consider was 5mm. 
A correlation between tumor expansion and a local MVD value is visible in our model only in 
the case when the original MVD is too low to meet the metabolic demand of the TC-s. In this 
case tumor growth will occur and sustain only if GF production is sufficient to stimulate 
sprouting in the peritumoral region (θGF is small or RGF is large), MVD must be elevated here. 
In the tumor center the MVD depends on the vessel collapse probability, thus can be larger 
or smaller than, or equal to the normal tissue MVD. On the other hand if the original MVD is 
large, there is no correlation between tumor growth and increased (outside) or decreased 
(inside) levels of MVD, neither locally nor globally. Based on this general behavior of our 
model we conclude that  MVD even when measured in different regions of the tumor is not a 
reliable diagnostic tool to predict the growth of a single tumor. The correlation found between 
central MVD of human melanoma and the outcome of the disease (Döme et al., 2002) is 
probably due to metastasis formation which we did not consider here.  
Conclusion: On the basis of a theoretical model, tested on experimental data for human 
melanoma, it was shown that the microvascular environment of the host is the dominant 
condition for tumor progression, once this is initiated. Microvascular density within the tumor 
can be drastically decreased due to the instability of tumor vessels without disturbing the 
growth at the tumor periphery, implying that MVD measurements might be an unreliable 
diagnostic tool for tumor progression. The specific reduction of vessel density of the host 
tissue, in addition to the inhibition of growth factor production of tumor cells, appears to be 
the most efficient strategy to stop tumor growth.  
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Appendix: 
 
Here we consider a variant of our model in which the process of vessels collapse is 
uncorrelated with the blood flow pattern on the network. 
We change the definition of the model introduced in the main text by canceling the flow 
computation and introduce a fully stochastic vessel collapse with a probability pcollpase: 
Circulated vessels, which are surrounded by TCs, collapse with probability pcollpase=∆τ/Tcollapse. 
After each collapse event e(r,τ)→0 first the set of circulated sites Scirc(τ) and then coxy(r,τ) is 
updated. Vessels that have a radius that is larger than a certain threshold rstab are supposed 
to be stable and cannot collapse any more (without any stabilization mechanism all vessels 
would eventually vanish). 
Fig. 11 shows the result of the simulation of this model with for different values for pcollpase 
(and other model parameters as in the base case) and demonstrates that the absence of a 
correlation between vessel collapse and blood flow leads to unrealistic vessel morphologies 
and a sharp percolation transition from configurations with small disconnected necrotic 
regions for small  collapse probabilities to configurations consisting only of small annulus of 
viable tumor cells.  
A more detailed analysis (data not shown) reveals a sharp percolation transition takes place 
at pcollapse=0.049 which is in the same universality class as conventional percolation (Stauffer 
and Aharony, 1992): Essentially in this model variant the vessels can collapse only for a fixed 
time interval – starting at the point when the tumor grows over them and ending at the point 
when they reach the stabilization radius (note that the radius grows linear in time once 
vessels are surrounded by TCs). The collapse rate multiplied with this time interval yields the 
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total probability with which a vessel segment is removed. This process leads naturally to a 
connectivity percolation transition, and much earlier (i.e. for smaller values of pcollapse) to a bi-
connectivity percolation transition.  
 
 21
 References 
 
Alarcón, T., H.M. Byrne, P.K. Maini. 2003. A cellular automaton model for tumour growth in 
inhomogeneous environment. J. Theor. Biol. 225:257-274. 
Anderson, A. R. A., M.A.J. Chaplain. 1998. Continuous and discrete mathematical models of 
tumor-induced angiogenesis. Bull. Math. Biol. 60:857-900. 
Boucher, Y.,  R.K. Jain. 1992. Microvascular pressure is the principal driving force for 
interstitial hypertension in solid tumors - implications for vascular collapse. Cancer Res. 
52:5110-5114. 
Boucher, Y., M. Leunig, R.K. Jain. 1996. Tumor angiogenesis and interstitial hypertension. 
Cancer Res. 56:4264-4266. 
Burri, P.H., R. Hlushchuk, V. Djonov. 2004. Intussusceptive angiogenesis: Its emergence, its 
characteristics, and its significance. Dev. Dyn. 231:474-488. 
Carmeliet, P., R.K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-
257. 
Cullen, J. P., S. Sayeed, R.S. Sawai, N.G. Theodorakis, P.A. Cahill, J.V. Sitzmann, E. M. 
Redmond. 2002. Pulsatile flow-induced angiogenesis - Role of G(i) Subunits. Arterioscler. 
Thromb. Vasc. Biol. 22:1610-1616. 
Davies P. F. 1995. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75:519-
560. 
Dimmeler, S., A.M. Zeiher. 2000. Endothelial cell apoptosis in angiogenesis and vessel 
regression. Circ. Res. 87:434-439. 
Döme, B., S. Paku, B. Somlai, J. Tímár. 2002. Vascularization of cutaneous melanoma 
involves vessel co-option and has clinical significance. J. Path. 197:355-362. 
Eden,  M. (1961) in Proceedings of the 4th Berkley Symposium Mathematics and Probability, 
ed. Neyman, J. (University of California Press, Berkley, 1961), p. 223-240. 
 22
Folkman J., M. Bach, J.W. Rowe, F. Davidoff, P. Lambert, C. Hirsch, A. Goldberg, H.H. Hiatt, 
J. Glass, E. Henshaw. 1971. Tumor angiogenesis – therapeutic implications. N. Engl. J. 
Med. 285: 1182-1186. 
Fukumura, D., F. Yuan, W.L. Monsky, Y. Chen, R.K. Jain. (1997). Effect of host 
microenvironment on the microcirculation of human colon adenocarcinoma. Am.J. Pathol. 
151:679-688. 
Gazit, Y., D.A. Berk, M. Leunig, L.T. Baxter, R.K. Jain. 1995. Scale-invariant behavior and 
vascular network formation in normal and tumor tissue. Phys. Rev. Lett. 75:2428–2431. 
Goerges, A. L., M.A. Nugent. 2004. pH regulates vascular endothelial growth factor binding 
to fibronectin - A mechanism for control of extracellular matrix storage and release. J. Biol. 
Chem. 279:2307-2315.  
Griffon-Etienne, G., Y. Boucher, C. Brekken, H.D. Suit, R.K. Jain. 1999. Taxane-induced 
apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid 
tumors: Clinical implications. Cancer Res. 59:3776-3782. 
Hanahan, D., and J. Folkman.1996. Patterns and emerging mechanisms of the angiogenic 
switch during tumorigenesis. Cell  86:353-364. 
Hashizume, H.,  P. Baluk, S. Morikawa, J.W. McLean, G. Thurston, S. Roberge, R.K. Jain, 
D.M. McDonald. 2000. Openings between defective endothelial cells explain tumor vessel 
leakiness. Am. J. of Pathol. 156:1363-1380. 
Helmlinger, G., P.A. Netti, H.C. Lichtenbeld, R.J. Melder, R.K. Jain. 1997. Solid stress 
inhibits the growth of multicellular tumor spheroids. Nat. Biotechnol. 15 :778-783. 
Hirst, D.G., J. Denekamp, B. Hobson. 1982. Proliferation studies of the endothelial and 
smooth-muscle cells of the mouse mesentery after irradiation. Cell Tissue Kinet. 15:251-
261. 
Hlatky, L., P. Hahnfeldt, J. Folkman. 2002 Clinical application of antiangiogenic therapy: 
Microvessel density, what it does and doesn't tell us. J. Nat. Cancer Inst. 94:883-893.  
 23
Holash, J., P. C. Maisonpierre, D. Compton, P. Boland, C.R. Alexander, D. Zagzag, G.D. 
Yancopoulos, S.J. Wiegand. 1999. Vessel cooption, regression, and growth in tumors 
mediated by angiopoietins and VEGF. Science 284:1994-1998. 
Holash, J., S.J. Wiegand, G.D. Yancopoulos. 1999 New model of tumor angiogenesis: 
dynamic balance between vessel regression and growth mediated by angiopoietins and 
VEGF. Oncogene 18:5356-5362. 
Ishida, T., Takahashi, M., Corson, M.A., Berk, B.C. (1997) Fluid shear stress-mediated signal 
transduction: How do endothelial cells transduce mechanical force into biological 
responses? Ann. N. Y. Acad. Sci. 811, 12-24. 
Iyer, N. V., L.E. Kotch, F. Agani, S.W. Leung, E. Laughner, R.H. Wenger, M. Gassmann, J.D. 
Gearhart, A.M. Lawler, A.Y. Yu, G.L. Semenza. 1998. Cellular and developmental control 
of O-2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12:149-162. 
Jimenez, B., O. V. Volpert, S. E. Crawford, M. Febbraio, R. L. Silverstein, N. Bouck. 2000. 
Signals leading to apoptosis-dependent inhibition of neovascularization by 
thrombospondin-1. Nat. Med. 6:41-48. 
Levine, H. A., S. Pamuk, B.D. Sleeman, M. Nilsen-Hamilton. 2001. Mathematical modeling of 
capillary formation and development in tumor angiogenesis: Penetration into the stroma. 
Bull. Math. Biol. 63:801-863. 
Lyden, D., K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chadburn, B. Heissig, W. 
Marks, L. Witte, Y. Wu, D. Hicklin, Z.P. Zhu, N.R. Hackett, R.G. Crystal, M.A.S. Moore, 
K.A. Hajjar, K. Manova, R. Benezra, S. Rafii. 2001. Impaired recruitment of bone-marrow-
derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and 
growth. Nat. Med. 7: 1194-1201. 
Mandelbrot, B. B. 1983. The Fractal Geometry of Nature: W. H. Freeman, New York. 
Maisonpierre, P.C., C. Suri, P.F. Jones, S. Bartunkova, S. Wiegand, C. Radziejewski, D. 
Compton, J. McClain, T.H. Aldrich, N. Papadopoulos, T.J. Daly, S. Davis, T.N. Sato, G.D. 
Yancopoulos. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo 
angiogenesis. Science 277:55-60. 
 24
Maxwell, P.H., G.U. Dachs, J.M. Gleadle, G.L. Nicholls, A.L. Harris, I.J. Stratford, O. 
Hankinson, C.W. Pugh, P.J. Ratcliffe. 1997. Hypoxia-inducible factor-1 modulates gene 
expression in solid tumors and influences both angiogenesis and tumor growth. Proc. 
Natl. Acad. Sci. USA 94:8104-8109.   
Milkiewicz, M., M.D. Brown, S. Egginton, O. Hudlicka. 2001 Association between shear 
stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation 8, 229-241. 
Minchenko, A., I. Leshchinsky, I. Opentanova, N.L. Sang, V. Srinivas, V. Armstead, J. Caro. 
2002. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-
kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene - Its possible role in the Warburg 
effect. J. Biol. Chem. 277:6183-6187. 
Nehls, V., R. Herrmann, M. Huhnken. 1998 Guided migration as a novel mechanism of 
capillary network remodeling is regulated by basic fibroblast growth. Histochem. Cell Biol. 
109:319-329. 
O'Reilly, M.S., L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y.H. 
Cao, E.H. Sage, J. Folkman.1994. Angiostatin – a novel angiogenesis inhibitor that 
mediates the suppression of metastatses by a Lewis lung-carcinoma. Cell 79:315-328.  
O'Reilly, M.S., T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane, E. Flynn, J.R. Birkhead, 
B.R. Olsen, J. Folkman. 1997. Endostatin: An endogenous inhibitor of angiogenesis and 
tumor growth. Cell  88:277-285. 
Paku, S. 1998. Current concepts of tumour-induced angiogenesis. Pathol. Oncol. Res. 4:62-
75. 
Plate, K. H., G. Breier, H.A. Weich, W. Risau. 1992. Vascular endothelial growth-factor is a 
potential tumor angiogenesis factor in human gliomas invivo. Nature 359:845-848. 
Plate, K. H., and W. Risau.1995. Angiogenesis in malignant gliomas. Glia 15:339-347. 
Pries, A.R., T.W. Secomb, P. Gaehtgens. 1995. Design principles of vascular beds. Circ. 
Res. 77:1017-1022. 
 25
Ramanujan, S., G.C. Koenig, T.P. Padera, B.R. Stoll, R.K. Jain. 2000. Local imbalance of 
proangiogenic and antiangiogenic factors: A potential mechanism of focal necrosis and 
dormancy in tumors.  Cancer Res. 60:1442-1448. 
Risau, W. 1997. Mechanisms of angiogenesis. Nature 386:671-674. 
Shweiki, D., A. Itin, D. Soffer, E. Keshet. 1992. Vascular endothelial growth-factor induced by 
hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845. 
Stauffer, D. and A. Aharony. 1992. Introduction to Percolation Theory, 2nd ed. Taylor & 
Francis, London. 
Tarjan R. 1972. Depth-first search and linear graph algorithms. SIAM J. Comput. 1:146-160.  
Thompson, W.D., K.J. Shiach, R.A. Fraser, L.C. Mcintosh, J.G. Simpson. 1987. Tumors 
acquire their vasculature by vessel incorporation, not vessel ingrowth. J. Path. 151:323-
332. 
Van Kampen, N.G. 1992. Stochastic processes in physics and chemistry. North Holland, 
Amsterdam 
Yu, J. L., J.W. Rak, B.L. Coomber, D.J. Hicklin, R.S. Kerbel. 2002. Effect of p53 status on 
tumor response to antiangiogenic therapy. Science 295:1526-1528. 
Zhou, M., R.L. Sutliff, R.J. Paul, J.N. Lorenz, J.B. Hoying, C.C. Haudenschild, M.Y. Yin, J.D. 
Coffin, L. Kong, E.G. Kranias, W.S. Luo, G.P. Boivin, J. Duffy, S.A. Pawlowski, T. 
Doetschman. 1998. Fibroblast growth factor 2 control of vascular tone. Nat. Med. 4:201-
207. 
 26
Tables 
 
Table 1: Variables defining the state at site r at time τ 
e 0/1: EC or vessel absent/present 
er ∈[0,rmax], radius of vessel 
eQ ≥0, blood flow rate through vessel segment 
ef ≥0, shear stress on vessel wall 
t 0/1 : TC absent/present 
tuO ∈[0,Tmax], time of TC in underoxygenated state
coxy ≥0; oxygen concentration field 
cGF ≥0; growth factor concentration field 
 
Table 2: Model parameters 
∆r lattice constant: space discretization 10µm 
∆τ length of time step: time discretization 1h 
MVD0 original MVD  100/mm2
TC0 original tumor size  103-105
RGF growth factor diffusion radius ~100-400µm
Roxy oxygen diffusion radius ~100-150µm
θGF growth factor threshold 10-3-10-1
θoxy,EC oxygen threshold for Ecs 10-2-10-1
θoxy,TC oxygen threshold for TCs 0.1⋅θoxy,EC
Tt TC proliferation time 10∆τ=10h 
Te EC proliferation time 40∆τ=40h 
r0 initial vessel radius 1∆r=10µm 
rmax maximum vessel radius 3.5r0=35µm 
Mmax maximum sprout migration distance 10∆r=100µm
Tcollapse collapse time of critical vessels 10-100Te
fcrit critical shear stress on vessel walls 0.2-0.8 f0
TuO maximum TC survival time in hypoxia 100∆τ=100h
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Figure legends 
 
 
Fig.1a-d: Series of images showing the time evolution of the tumor and vessel configurations 
in our model at different time steps. 
The normal vasculature, to be seen far away from the tumor,  is characterized by straight 
lines arranged in a grid like network with a characteristic line-to-line distance (here 100µm) 
defining the normal MVD (here 100/mm2). The color of the blood vessels indicate their blood 
flow. Blue corresponds to normal, red to high and yellow to low flow values. The thickness of 
the lines represents the vessel radius. Sites occupied by TCs are color coded in green to 
black, increasing darkness indicating their age. White regions are empty sites, i.e. inside the 
tumor the necrotic regions. For the parameter values see the text and table 2. Only the part 
of the whole system (L=512) containing the peritumoral region is shown. 
(a) One time step (t=1) after the initialization of the system: The irregular structure of the 
initial tumor is typical for an Eden cluster (Eden, 1961). One sees that 5 new vessels are 
formed within one time step at the boundary. (b) t=50: Extensive formation of new vessels 
can be seen at the peritumoral region. New vessels frequently have lower blood flow values 
than vessels in the original network. The original vessels are almost all intact. (c) t=100: The 
progressive tumor growth pushes the peritumoral plexus further into the normal tissue. Inside 
the tumor, MVD is drastically reduced leaving large regions of the tumor underoxygenated. 
(d) t=200: TCs inside the low MVD region visible in (c) died after being 100 times steps in an 
underoxygenatd state leaving a large necrotic region to be seen as a white spots.  
 
Fig. 2: The state of the system with the same parameters as in Fig. 1 after t=1000 time 
steps. The color coding is the same as in Fig. 1. The lateral size of the region shown is 
5.1mm. 
 
Fig. 3: As a function of the radial distance r from the tumor center  (measured in units of ∆r) 
and the time t  (measured in units of ∆t) it is shown: (a) the average tumor density DT(r,t) as 
defined by the average number of TCs per lattice sites at time t, (b) average microvascular 
density MVD(r,t), the average number of vessels per lattice site, relative to normal tissue 
MVD0. The average is done over an annulus of width 10∆r with central radius r.  
 
Fig. 4: As in Fig. 3 it is shown as a function of the radial distance r from the tumor center and 
the time t: (a) the average vessel radius R(r,t), (b) the blood flow per vessel Q(r,t)=eq(r,t), (c) 
the shear stress F(r,t)=ef(r,t). (d) The difference  in the blood pressure inside the vessels 
(with respect to normal). Since the local blood pressure inside the vessels does not have the 
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radial symmetry of the other quantities studied in a-c we show the pressure field P(x,y) at 
time t=600 minus the normal pressure P0(x,y) at t=0 (i.e. for normal vascularization), where 
(x,y) are the coordinates of the vessels. One recognizes the spatial location and extent of the 
circular tumor in the middle. The global flow direction, enforced via the boundary conditions, 
is from left (0,0) to right (512,512). Looking along this direction, the pressure is decreased in 
front of the tumor (left) and increased at the back of the tumor (right). 
 
Fig. 5: Determination of the fractal dimension df of the vessel network at time t in the base 
case (Fig. 2 ) via the box-counting method: The number of Boxes of size L that is needed to 
cover completely the vasculature is plotted as a function of L in log-log scale. The slope df of 
the curve is the fractal dimension. We confined the measurement to annuli with fixed outer 
radius that is determined by the limit of the peritumoral plexus and with varying inner radius 
Ri. The slope of the curves decreases with increasing Ri: df=1.85+/-0.05 for Ri =0 (full 
squares, which corresponds to the complete tumor vasculature) and df=1.60+/-0.05 for Ri 
=200 (which corresponds to the peritumoral plexus exclusively), indicating that the fractal 
dimension is not a homogeneous measure over all regions of the tumor vasculature. 
 
Fig. 6: Oxygen concentration field coxy(x,y) of the original vasculature for different lattice 
constants a (i.e. different MVD0) and different values for Roxy, which is chosen to be equal to 
a. The variation of coxy between the vessels is only a few percent and the average value 
decreases with decreasing a (or MVD0). 
 
Fig. 7: a) (Top) Growth factor concentration field cGF(x,y) for an ideal circular tumor of density 
one and radius 50∆r and RGF=20∆r. b) (Bottom) cGF as a function of the distance from the 
tumor surface for the ideal tumor of a for different RGF. 
 
Fig. 8: Effect of a large value of RGF on the tumor morphology. Top: shows a configuration 
after 1000 time steps for RGF=40∆r but all other parameters as in the base case. Compared 
to Fig. 2 the necrotic regions are much smaller and the MVD is homogeneously increased 
with the tumor. (Bottom): Parameters as in the top figure except the critical shear stress fcrit, 
which is now 0.7 (instead of 0.5). Whereas the morphology in the top figure is rather stable 
even for large collapse probabilities only a small variation of fcrit produces large necrotic 
regions and decreased MVD within the tumor. 
 
Fig. 9: Sequence of configurations with increasing collapse probability (from left to right it is 
pcollapse=0.02, 0.04, 0.1, 0.5) and fcrit=0.5. Here we have chosen  RGF=10, θGF=0.01 and the 
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other parameters as in the base case. The same seed for the random number generator for 
the simulations in all cases is chosen to emphasize the effect of the variation of pcollapse. 
 
Fig.10: a) The total volume of the necrotic regions with the tumor divided by the total tumor 
mass as a function of time for different collapse probabilities (parameters as in Fig. 9). b) The 
relative deficit/excess volume of the vasculature as a function of time for different collapse 
probabilities (parameters as in Fig. 9). 
 
Fig. 11: Tumor and vessel configurations after time t=2000 for the model with uncorrelated 
vessel collapse (i.e. without blood flow and without a critical shear foce determining the 
vessel collpase) – from left to right it is pcollapse=0.04, 0.05 and 0.06. The morphology of the 
vessel network is much more tortuous, in particular a global directedness of the vessel is 
absent and only for values of pcollapse around 0.05 the inner region of the tumor is neither 
completely filled nor completely void with thick vessels threading the tumor.  
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